Yip Tszho (Zico)

Yip Tszho (Zico), Chief Executive of Lonvi Biosciences and a pioneer in longevity research, dives into the groundbreaking development of PCC1, a senolytic pill aimed at extending human lifespans. He explains how PCC1 selectively targets and eliminates senescent cells, possibly increasing lifespan by 9.4% in studies. The conversation explores the potential health benefits of this drug, including improved immune response and skin health. Yip also shares insights on the future of Chinese longevity science and the importance of biomarker-driven treatments.